| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 487,1 k € | +30.0% | 374,6 k € | -6.7% | 401,7 k € | -34.7% | 615,1 k € | +150.9% | 245,1 k € | -18.7% | 301,4 k € | — | — | — | 125,7 k € | +17.2% | 107,3 k € | |||||
| Gross margin | 406,2 k € | +35.1% | 300,7 k € | -8.4% | 328,3 k € | -39.6% | 543,7 k € | +199.6% | 181,4 k € | -9.0% | 199,5 k € | -12.3% | 227,4 k € | +95.5% | 116,3 k € | +15.8% | 100,5 k € | +31.1% | 76,7 k € | +56.3% | 49,1 k € | |
| EBITDA | 405,1 k € | +35.3% | 299,4 k € | -8.7% | 327,8 k € | -39.6% | 543,2 k € | +200.1% | 181,0 k € | -8.7% | 198,4 k € | -12.4% | 226,5 k € | +95.0% | 116,1 k € | +16.0% | 100,1 k € | +31.1% | 76,4 k € | +55.7% | 49,1 k € | |
| Operating profit | 404,2 k € | +35.8% | 297,6 k € | -8.9% | 326,5 k € | -39.8% | 542,1 k € | +215.5% | 171,8 k € | -9.2% | 189,2 k € | -12.9% | 217,3 k € | +95.5% | 111,2 k € | +16.8% | 95,2 k € | +33.1% | 71,5 k € | +46.7% | 48,7 k € | |
| Profit/loss | 305,1 k € | +37.5% | 222,0 k € | -10.7% | 248,7 k € | -38.8% | 406,3 k € | +223.3% | 125,7 k € | -10.8% | 140,9 k € | -11.5% | 159,3 k € | +119.5% | 72,6 k € | +10.7% | 65,5 k € | +32.2% | 49,6 k € | +55.4% | 31,9 k € | |
| Equity | 751,2 k € | +26.0% | 596,1 k € | +13.7% | 524,1 k € | +23.2% | 425,4 k € | +151.7% | 169,0 k € | -61.9% | 443,3 k € | +46.6% | 302,5 k € | +111.2% | 143,2 k € | +1.8% | 140,6 k € | +87.3% | 75,1 k € | +472.7% | 13,1 k € | |
| Total assets | 926,9 k € | +23.5% | 750,8 k € | -2.5% | 770,3 k € | +14.9% | 670,5 k € | +15.5% | 580,4 k € | +30.0% | 446,4 k € | +34.4% | 332,2 k € | +46.2% | 227,2 k € | +32.7% | 171,2 k € | +75.9% | 97,3 k € | +76.5% | 55,1 k € | |
| Cash | 203,5 k € | +6.6% | 190,9 k € | -21.1% | 242,1 k € | +15.6% | 209,4 k € | -62.5% | 558,1 k € | +28.8% | 433,2 k € | +42.1% | 305,0 k € | +40.5% | 217,0 k € | +39.1% | 156,0 k € | +100.3% | 77,9 k € | +45.6% | 53,5 k € | |
| Debts | 175,7 k € | +13.6% | 154,7 k € | -37.1% | 246,0 k € | +0.4% | 245,1 k € | -40.4% | 411,4 k € | +13272.4% | 3,1 k € | -89.6% | 29,7 k € | -64.7% | 84,0 k € | +175.1% | 30,5 k € | +37.5% | 22,2 k € | -47.1% | 42,0 k € | |
Private limited company · Ans · incorporated on 20/01/2014
Private limited company profitable and well capitalised. Cash position rising (+6.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
GITHAHO BIOCLIN is a Private limited company incorporated in 2014. Its main activity is: Other human health activities. Its registered office is in Ans.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette